Medicinal Product Shortages - update - 26 April 2023

Notice type: Advisory

Date: 26/04/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

 

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Allopurinol Teva 300mg Tablets

PA0749/099/003

Teva Pharma B.V.

Allopurinol

Aminophylline Hydrate 25mg/ml Solution for Injection

PA0073/099/001

Mercury Pharmaceuticals (Ireland) Ltd

Aminophylline Hydrate

Atozet 10mg/10mg Film Coated Tablets

PA23198/022/01

Organon Pharma (Ireland) Limited

Ezetimibe & atorvastatin

Atozet 10mg/20mg Film Coated Tablets

PA23198/022/002

Organon Pharma (Ireland) Limited

Ezetimibe & atorvastatin

Azyter 15 mg/g Eye Drops

PA1107/004/001

Laboratoires Thea

Azithromycin

Benylin Children’s Dry Coughs Syrup

PA0330/022/001

Johnson & Johnson (Ireland) Limited

Diphenhydramine & levomenthol

Benylin Cough Medicine Syrup

PA0330/019/001

Johnson & Johnson (Ireland) Limited

Diphenhydramine & levomenthol

Caelyx pegylated liposomal 2mg/ml

(25ml presentation)

EU/1/96/011/003-004

Baxter Holding B.V.

Doxorubicin

Canesten 500mg Pessary

PA1410/039/009

Bayer Limited

Clotrimazole

Canesten Combi Pessary & Cream

PA1410/039/001

Bayer Limited

Clotrimazole

Flutiform 125 microgram/5 microgram per metered dose Pressurised Inhalation, Suspension

PA1688/013/002

Mundipharma Pharmaceuticals Limited

Fluticasone & formoterol

Gonal-F

EU/1/95/001/025

Merck Europe B.V.

Follitropin alfa

Migraleve Film Coated Tablets

PA0330/030/003

Johnson & Johnson (Ireland) Limited

Buclizine, paracetamol & codeine

Moviprep Orange Powder for Oral Solution

PA1336/001/002

Norgine B.V.

Macrogol 3350

 

Neurostil 100mg Capsules

PA0749/164/001

Teva Pharma B.V.

Gabapentin

Neurostil 400 mg capsules

PA0749/164/003

Teva Pharma B.V

Gabapentin

Nebivolol Teva 5mg Tablets

PA0749/078/001

Teva Pharma B.V.

Nebivolol

Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml Nasal Spray, Solution

PA0678/131/001

GlaxoSmithKline Consumer Healthcare (Ireland) Limited

Xylometazoline & ipratropium bromide

Otrivine Sinusitis Relief 0.1% w/v Nasal Spray, Solution

PA0678/120/003

GlaxoSmithKline Consumer Healthcare (Ireland) Limited

Xylometazoline

OxyNorm Dispersa 5mg Orodispersible Tablets

PA1688/006/007

Mundipharma Pharmaceuticals Limited

Oxycodone

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Distaclor 125mg/5ml Granules for Oral Suspension

PA1226/001/002

Flynn Pharma Limited

Cefaclor

Distaclor 250mg/5ml Granules for Oral Suspension

PA1226/001/003

Flynn Pharma Limited

Cefaclor

Ilvico Cold and Flu Film Coated Tablets

PA22703/001/001

P&G Health Germany GmbH

Paracetamol, brompheniramine & caffeine

Ixiaro

EU/1/08/501/1-2

Intercell Austria AG

Inactivated je virus

Mestinon 60mg Tablets

PA2010/052/001

Mylan IRE Healthcare Limited

Pyridostigmine

Metformin Hydrochloride 500mg/5ml Oral Solution

PA23081/008/001

Taw Pharma (Ireland) Ltd

Metformin

Optiray 300 mg I/ml PFS solution for injection

PA0686/007/004

Guerbet

Ioversol

Spasmonal Forte 120mg Hard Capsules

PA2010/043/002

Mylan IRE Healthcare Limited

Alverine

Tritace 10mg Tablets

PA0540/084/008

Sanofi-Aventis Ireland Limited T/A SANOFI

Ramipril

Warfant 5mg Tablets

PA0073/139/003

Mercury Pharmaceuticals (Ireland) Ltd

Warfarin

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back